Stock Price & Analysis

The S1 support level for ANIK Stock is $15.52 ,The R1 resistant level for ANIK Stock is $16.91.

As of the end of day on 2025-01-23, the price of ANIK Stock was $16.37.

The target price for ANIK Stock according to analyst rating is 25.00, with the highest price target at 25.00 and the lowest at 25.00. Analysts have a Moderate Buy rating on ANIK Stock overall.

The market cap of ANIK is $239.7M.

Anika Therapeutics, Inc. is a global joint preservation company. The Company creates and delivers advancements in early intervention orthopedic care, including in the areas of osteoarthritis (OA) pain management, regenerative solutions, and sports medicine. It is focused on developing, manufacturing and commercializing products on its hyaluronic acid (HA), technology platform. Its OA Pain Management product family consists of Monovisc and Orthovisc, its injectable, HA, OA Pain Management offerings are indicated to provide pain relief from osteoarthritis conditions; and Cingal, its novel, next generation, single-injection OA Pain Management product consisting of its proprietary cross-linked HA material combined with a steroid. Its Joint Preservation and Restoration product family consists of its portfolio of orthopedic regenerative solutions products utilizing HA, including Integrity, its new hyaluronic acid-based scaffold for rotator cuff and other tendon repairs.

ANIK has a total of 357 employees.